Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for Pain in Chronic Pancreatitis
NCT05925036Phase 1Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of mesenchymal stem cells in chronic pancreatitis (CP) and chronic pain (2 cohorts), sponsored by VA Office of Research & Development. Primary endpoint: Change in Izbicki pain score at 6 months. Started Jan 2024; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
chronic pancreatitis (CP)chronic pain
Beyond the preview
Go deeper on NCT05925036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925036.